Immune thrombocytopenia in children: consensus and controversies
Newly diagnosed immune thrombocytopenia (ITP) is a relatively common disorder of
childhood that does not require an exhaustive laboratory workup for diagnosis. A history and …
childhood that does not require an exhaustive laboratory workup for diagnosis. A history and …
A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group
C Neunert, KMJ Heitink‐Polle… - British Journal of …, 2023 - Wiley Online Library
Immune thrombocytopenia (ITP) in children is a relatively mild and self‐limited disorder with
the majority of children demonstrating normalization of platelet count by 12 months from …
the majority of children demonstrating normalization of platelet count by 12 months from …
Use of eltrombopag in children with chronic immune thrombocytopenia (ITP): a real life retrospective multicenter experience of the Italian Association of Pediatric …
P Giordano, G Lassandro, A Barone, S Cesaro… - Frontiers in …, 2020 - frontiersin.org
Background: The thrombopoietin receptor agonist eltrombopag has been shown to be safe
and effective for children with chronic immune thrombocytopenia (ITP). The aim of the …
and effective for children with chronic immune thrombocytopenia (ITP). The aim of the …
Fatigue in children and adolescents with immune thrombocytopenia
RF Grace, RJ Klaassen, KA Shimano… - British Journal of …, 2020 - Wiley Online Library
Immune thrombocytopenia (ITP), an acquired autoimmune disorder of low platelets and risk
of bleeding, has a substantial impact on health‐related quality of life (HRQoL). Patients with …
of bleeding, has a substantial impact on health‐related quality of life (HRQoL). Patients with …
Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia
A Casini, S von Mackensen, C Santoro… - Blood, The Journal …, 2021 - ashpublications.org
Due to the low prevalence of afibrinogenemia, epidemiologic data on afibrinogenemia are
limited, and no data are available on health-related quality of life (HRQoL). We conducted a …
limited, and no data are available on health-related quality of life (HRQoL). We conducted a …
Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice
X Cheng, LL Fu, J Ma, H Gu, Z Chen, L Zhao… - Blood …, 2021 - ashpublications.org
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with isolated
thrombocytopenia and risk of hemorrhage. Treatment with eltrombopag increases and …
thrombocytopenia and risk of hemorrhage. Treatment with eltrombopag increases and …
Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia
JD Grainger, T Kühne, J Hippenmeyer, N Cooper - Annals of Hematology, 2021 - Springer
Immune thrombocytopenia (ITP) is a disease of heterogenous origin characterized by low
platelet counts and an increased bleeding tendency. Three disease phases have been …
platelet counts and an increased bleeding tendency. Three disease phases have been …
儿童免疫性血小板减少症的规范治疗与管理
张爱军, 刘芹芹, 浦婷 - 临床儿科杂志, 2022 - jcp.xinhuamed.com.cn
免疫性血小板减少症(ITP) 是儿童时期最为常见的出血性疾病, 由多种自身免疫机制介导,
以孤立性血小板减少为主要临床特点. 儿童ITP 通常急性起病, 相当比例的患儿可追溯到前驱 …
以孤立性血小板减少为主要临床特点. 儿童ITP 通常急性起病, 相当比例的患儿可追溯到前驱 …
The role of romiplostim for pediatric patients with immune thrombocytopenia
H Al-Samkari, RF Grace… - Therapeutic advances in …, 2020 - journals.sagepub.com
The thrombopoietin receptor agonists (TPO-RAs) are a class of platelet growth factors used
to treat immune thrombocytopenia (ITP) in children and adults. Romiplostim is a peptide …
to treat immune thrombocytopenia (ITP) in children and adults. Romiplostim is a peptide …
[PDF][PDF] Trombocitopenia inmune. Guía de diagnóstico y tratamiento
H Donato, V Bacciedoni, MC Rapetti, G Elena… - Arch Argent Pediatr …, 2019 - sap.org.ar
El manejo de la trombocitopenia inmune es motivo de discusión en lo concerniente a
evolución, diagnóstico, pronóstico y tratamiento. Se han publicado varias guías que …
evolución, diagnóstico, pronóstico y tratamiento. Se han publicado varias guías que …